Current status and prospect of global development of lung transplantation
10.3969/j.issn.1674-7445.2022.04.002
- VernacularTitle:肺移植全球发展概况与展望
- Author:
Guohui JIAO
1
;
Zitao WANG
;
Jingyu CHEN
Author Information
1. The Affiliated Wuxi People's Hospital of Nanjing Medical University, Jiangsu Lung Transplant Center, Wuxi Lung Transplant Center, Wuxi 214000, China
- Publication Type:Research Article
- Keywords:
Lung transplantation;
Novel coronavirus pneumonia;
Acute respiratory distress syndrome (ARDS);
Donation after cardiac death (DCD);
Ex vivo lung perfusion (EVLP);
Lung allocation score (LAS);
Extracorporeal membrane oxygenation (ECMO);
Xenotransplantation
- From:
Organ Transplantation
2022;13(4):417-
- CountryChina
- Language:Chinese
-
Abstract:
During the novel coronavirus pneumonia (COVID-19) pandemic from 2020 to 2021, lung transplantation entered a new stage of development worldwide. Globally, more than 70 000 cases of lung transplantation have been reported to the International Society for Heart and Lung Transplantation (ISHLT). With the development of medical techniques over time, the characteristics of lung transplant donors and recipients and the indications of pediatric lung transplantation recipients have undergone significant changes. Application of lung transplantation in the treatment of COVID-19-related acute respiratory distress syndrome (ARDS) has also captivated worldwide attention. Along with persistent development of lung transplantation, it will be integrated with more novel techniques to make breakthroughs in the fields of artificial lung and xenotransplantation. In this article, research progresses on the characteristics of lung transplant donors and recipients around the world were reviewed and the development trend was predicted, enabling patients with end-stage lung disease to obtain more benefits from the development of lung transplantation technique.
